Published: 14 August 2020
Author(s): Alexandre Terré, Samuel Deshayes, Léa Savey, Gilles Grateau, Sophie Georgin-Lavialle
Issue: January 2021
Section: Letter to the Editor

AA amyloidosis (AAA) is a major complication of chronic inflammation. It is the consequence of the deposition of fibrils of serum amyloid A protein (SAA) in tissues [1]. Lachman et al. prospectively studied AAA natural history and outcome, and highlighted several risk factors for death, such as for example the cause of AAA, or the severity of kidney involvement [2]. Nevertheless, AAA's epidemiology has changed in recent years [3], with fewer cases of AAA caused by inflammatory rheumatisms, whereas new causes are rising, such as obesity [4].

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.